Industry News

Dizal Showcases its Strong Hematology Pipeline with New Data from Golidocitinib and Birelentinib at ASH 2025

SHANGHAI, Dec. 9, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for cancer and immunological diseases, announced new data from its hematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting. Highlights includ...

2025-12-09 18:00 2665

VINSSEN and ILDO F&C Form Exclusive Alliance to Advance Composite Bipolar Plate Technology for Hydrogen Systems

Joint innovation targets lower costs, higher durability, and broader applications across the hydrogen value chain SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ -- VINSSEN , a maritime decarbonization technology company specializing in hydrogen fuel cells and integrated s...

2025-12-09 16:46 4077

AI Infrastructure Company EverMind's EverMemOS Aims to Give AI Agents Durable, Coherent, and Continuously Evolving "Souls"

SAN MATEO, Calif., Dec. 9, 2025 /PRNewswire/ -- AI infrastructure company  EverMind has announced a major milestone in long-term memory research with its newly released EverMemOS achieving 92.3% accuracy on LoCoMo and 82% on LongMemEval-S—two of the field's most authoritativ...

2025-12-09 16:11 3086

NUS scientists create microneedle system to deliver biofertiliser directly into plants, boosting growth with less waste

A dissolving patch delivers beneficial microbes into leaves and stems, speeding growth in vegetables while using over 15 per cent less biofertiliser than soil application SINGAPORE, Dec. 9, 2025 /PRNewswire/ -- Researchers at the National University of Singapore (NUS) have developed dissolving m...

2025-12-09 16:01 4020

Phase II Data of Cadonilimab Regimen as Neoadjuvant Therapy for Resectable Gastric Cancer Presented at ESMO Asia 2025

HONG KONG, Dec. 9, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that data from the Phase II study (COMPASSION-25) for its first-in-class PD-1/CTLA-4 bispecific antibody, cadonilimab, in combination with SOX regimen (oxaliplatin + tegafur/gimeracil/oteracil) as n...

2025-12-09 15:50 2482

ASPEED Technology Wins GSA Best Financially Managed Semiconductor Company Award

HSINCHU, Dec. 9, 2025 /PRNewswire/ -- ASPEED Technology, the world's leading provider of Baseboard Management Controller (BMC) SoCs, today announced that it has been awarded the 2025"Best Financially Managed Semiconductor Company Award" (Achieving Up toUS$1 Billion in Annual Sales) at the Global ...

2025-12-09 15:30 1785

Hanwha Life CGO Dong-Won Kim Reaffirms Commitment to Strengthening South Korea-UAE Financial Cooperation at ADFW 2025

- "Advancing the South Korea–UAE '100-Year Partnership' Through Finance," the CGO said in his Opening Address - Unveils Vision for Building a Next-Generation Global Financial Ecosystem With Abu Dhabi - Highlights Future Agendas Including Co-Investments and Digital Asset Platform Development SEOU...

2025-12-09 15:29 2567

GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy

YONGIN, South Korea, Dec. 9, 2025 /PRNewswire/ -- GC Genome, a leading clinical genomics and liquid biopsy company, announced that its study analyzing cell-free DNA (cfDNA) fragmentation patterns in 1,154 healthy individuals has been published in Clinical Chemistry (Impact Factor 6.3, 2025). The ...

2025-12-09 14:54 4227

Keio Plaza Hotel Tokyo Wins Grand Prize at Eco Mark Award 2025

- Keio Plaza Hotel Recognized for Its Company-wide Sustainability Promotion, Food Waste Reduction and Installation of Clothing Collection Boxes - TOKYO, Dec. 9, 2025 /PRNewswire/ -- Keio Plaza Hotel Co., Ltd. received the highest award, the Grand Prize, at the Eco Mark Award 2025, an awards progr...

2025-12-09 14:00 1791

MegazoneCloud Accelerates U.S. Expansion… Targets 10x U.S. Revenue Growth in 2026

-    Media Briefing at AWS re:Invent to Announce 2026 Business Plan and Strategy -    To Proactively Respond to High-Growth Market Momentum, MegazoneCloud U.S. to Dramatically Expand Full-Time Headcount in 2026 -    Building AWS-Centered Local Leadership and Strengthening Global Partnerships to Ac...

2025-12-09 10:11 3814

Significant Improvement in Quality of Life Reported in Updated HARMONi-6 Data for Ivonescimab at ESMO Asia

HONG KONG, Dec. 8, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that at the 2025 ESMO Asia Congress, updated results from the pivotal Phase III HARMONi-6 study (AK112-306) were shared in an oral presentation by ProfessorShun Lu from Shanghai Chest Hospital. The ...

2025-12-09 10:02 2989

Innovent Announces PECONDLE® (Picankibart Injection) Phase 3 Study (CLEAR-2) Meets Endpoints, Delivering Superior Long-Term Management Solution for Moderate-to-Severe Psoriasis

SAN FRANCISCO and SUZHOU, China, Dec. 8, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...

2025-12-09 08:00 2644

COSRX Joins the Inaugural Korean American Leaders in Hollywood (KALH) Honors to Celebrate Global Creativity and Representation

LOS ANGELES, Dec. 8, 2025 /PRNewswire/ -- COSRX, the award-winning K-beauty brand trusted worldwide for its science-backed and skin-friendly formulations, proudly served as the official skincare partner of the inaugural Korean American Leaders inHollywood (KALH) Honors, a landmark event recognizi...

2025-12-09 02:00 4398

Moutai Cultural Exhibition Ignites U.S. Audience with Immersive Journey Through a Century of Cultural Heritage

SAN FRANCISCO, Dec. 8, 2025 /PRNewswire/ -- From December 7 to 8, Kweichow Moutai celebrated a dual milestone - the 110th anniversary of its award-winning debut at the 1915 Panama-Pacific International Exposition and the 10th anniversary of San Francisco Moutai Day - through a dynamic series of e...

2025-12-09 00:13 2089

STRADVISION Announces Next Phase of Cloud-Driven Innovation in Collaboration with AWS

-      Head of Data Innovation Center presents STRADVISION's next roadmap at AWS re:Invent SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- STRADVISION , a global leader in AI-based vision perception technology for vehicles, today announced its forward-looking ...

2025-12-09 00:00 2457

Convergen Secures $10 Million Seed Funding to Advance TrimTAC Platform for Neurodegeneration & beyond

SUZHOU, China, Dec. 8, 2025 /PRNewswire/ -- Convergen, a biotech company pioneering targeted protein degradation (TPD) therapies for diseases driven by pathological protein aggregates, today announced the closing of a$10 million Seed financing round. The round was invested by Qiming Venture Partn...

2025-12-08 23:00 2281

AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C Reports Unaudited Financial Results for the Six Months Ended June 30, 2025

DUBAI, UAE, Dec. 8, 2025 /PRNewswire/ -- AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C, (the "Company") (Nasdaq: AHMA), a United Arabic Emirates-based MICE (meetings, incentives, conferences, and exhibitions) and tourism services provider, today announced its unaudited financial results for the six m...

2025-12-08 22:15 4729

ALR TECHNOLOGIES TO RELAUNCH THE GLUCURVE PET CGM IN JANUARY 2026

SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- ALR Technologies SG Ltd ("ALRT" or the " Company") (OTC: ALRTF), the diabetes management company, announces the successful completion of internal manufacturing testing on the GluCurve Pet CGM ("GluCurve") showing accuracy results comparative to the leading v...

2025-12-08 22:14 3893

PCBAIR Unveils 8-Layer Glass Core PCB Manufacturing for Next-Gen AI & HPC

SHENZHEN, China, Dec. 8, 2025 /PRNewswire/ -- PCBAIR announced the launch of its advanced 8-layer Glass Core PCB manufacturing capabilities, combining proprietary Through Glass Via (TGV) technology with multi-layer redistribution layers (RDL). The new glass substrates achieve superior signal inte...

2025-12-08 22:00 1946

Lunit Submits 510(k) Application for Image-Based Breast Cancer Risk Prediction Model

Submission marks a key regulatory milestone toward bringing SEER-calibrated, imaging-based risk assessment to U.S. screening programs SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced that ...

2025-12-08 22:00 2905